Comparison of Standard Versus Low Bicarbonate Hemodialysis
Intradialytic Acid-base Changes and Organic Anion Production With Standard Versus Low Bicarbonate Hemodialysis
1 other identifier
interventional
10
1 country
1
Brief Summary
This study will compare acid-base changes during hemodialysis treatments with a standard dialysis bath versus a lower bicarbonate dialysis bath, and aims to define the factors that limit equilibration of the bicarbonate concentration in a patient's blood with that in the dialysate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started Jan 2013
Shorter than P25 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 24, 2013
CompletedFirst Posted
Study publicly available on registry
January 28, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedApril 30, 2019
June 1, 2013
5 months
January 24, 2013
April 26, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in beta-hydroxybutyrate clearance
Comparison between 2 hemodialysis treatments with different bicarbonate dialysis concentrations
1-2 weeks
Change in lactate clearance
Comparison between 2 hemodialysis treatments with different bicarbonate dialysis concentrations
1-2 weeks
Post-dialysis pH
1-2 weeks
Post-dialysis bicarbonate
1-2 weeks
Study Arms (1)
Low bicarbonate dialysis
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Receiving chronic thrice-weekly conventional hemodialysis for at least 3 months
- Age \> 18 years
You may not qualify if:
- Use of oral alkali within the previous month
- Hospitalization within the previous month
- Inability to provide written informed consent
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Montefiore Medical Center/Jack D. Weiler Hospital
The Bronx, New York, 10461, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthew K Abramowitz, MD, MS
Albert Einstein College of Medicine
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 24, 2013
First Posted
January 28, 2013
Study Start
January 1, 2013
Primary Completion
June 1, 2013
Study Completion
June 1, 2013
Last Updated
April 30, 2019
Record last verified: 2013-06